ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Profacgen Enhanced Its Stable Cell Line Construction Service Recently

By: Get News
Profacgen recently enhanced its stable cell line construction service for protein expression, aiming to help scientists meet their biological development needs.

New York, USA – July 28, 2022 – Profacgen, a world leader in serving life technology, recently enhanced its stable cell line construction service for protein expression, aiming to help scientists meet their biological development needs.

Stable cell lines are frequently employed in many crucial applications, such as the generation of biologics (like recombinant proteins and monoclonal antibodies), drug screening, and gene functional investigations.

For reliable and affordable protein production when a big quantity of recombinant protein is needed, stable expression line constructure is advised. A stable cell line is typically created in three steps: target gene delivery into the host cell, stable expression clone selection, and stability testing.

To assist clients in meeting their demands for biologics development, Profacgen offers development services that make use of cutting-edge technology and established knowledge. The company’s cell line development team works closely with the bioanalytical testing and manufacturing teams to provide high-performance, highly stable production cell lines in a variety of host cells within the quickest development cycle and to guarantee that processes and products are scalable to clinical and commercial scale.

For effective gene delivery and a high integration rate, Profacgen uses lentiviral vectors. Then, to choose for monoclones with stable expression and high yield, limited dilution and antibiotic screening are used. Profacgen can also employ flow cytometry to look for positive clones when fluorescent protein is fused to the target protein. In order to induce the expression of target gene, Profacgen additionally provides the creation of Tet-ON inducible stable cell lines.

To ensure integration of target gene and stable/inducible expression of the protein, Profacgen also provides PCR, qRT-PCR, microscopy, flow cytometry analysis and stability test based on diversified needs.

Moreover, Profacgen provides cell medium development and QC test service for cell line development service.

To know more detailed information about the updated stable cell line construction service for protein expression, please visit https://www.profacgen.com/stable-cell-line-construction.htm.

Media Contact
Company Name: Profacgen
Contact Person: Ellen
Email: Send Email
Phone: 1-516-855-7709
Country: United States
Website: https://www.profacgen.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.